5 Opioid Treatment Stocks

Page 5 of 5

1. Catalent Inc (NYSE:CTLT)

Last year, Catalent Inc (NYSE:CTLT) partnered with US WorldMeds to manufacture and distribute Lofexidine Hydrochloride in the US. Lofexidine, which in the UK is sold under the BritLofex brand name, is used to alliviate symptoms associated with opioid withdrawal. In November, US WorldMeds got the Priority Review of the NDA for Lofexidine and the Prescription Drug User Fee Act is expected in the second quarter of 2018.

pills-824994_1920

These are opioid treatment stocks that are engaged in selling drugs for various treatments of opioid addiction, from mitigating withdrawal symptoms to blocking the effects of opioids, as well as several companies that manufacture similar products. There are also companies that have analogues to the drugs discussed in this article under development. For example, Biocorrx Inc (OTCMKTS:BICX) and Therakine are working on an injectable naltrexone drug, and Insys Therapeutics Inc (NASDAQ:INSY) is developing a spray formulation of naloxone.

Disclosure: none

Page 5 of 5